April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Identification and Functional Characterization of TXNIP’s Phosphoproteome in the Human Diabetic Retina
Author Affiliations & Notes
  • Folami Lamoke
    Department Ophthalmology, Georgia Regents University, Augusta, GA
  • Srinivas Rao Sripathi
    Department of Biological Sciences, Michigan Tech University, Houghton, GA
  • Priyanka Thakur
    Department of Medicine, Georgia Regents University, Augusta, GA
  • Michael Duncan
    Department of Medicine, Georgia Regents University, Augusta, GA
  • Wan Jin Jahng
    Department of Petroleum Chemistry, American University of Nigeria, Adamawa, Nigeria
  • Manuela Bartoli
    Department Ophthalmology, Georgia Regents University, Augusta, GA
  • Footnotes
    Commercial Relationships Folami Lamoke, None; Srinivas Sripathi, None; Priyanka Thakur, None; Michael Duncan, None; Wan Jin Jahng, None; Manuela Bartoli, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4928. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Folami Lamoke, Srinivas Rao Sripathi, Priyanka Thakur, Michael Duncan, Wan Jin Jahng, Manuela Bartoli; Identification and Functional Characterization of TXNIP’s Phosphoproteome in the Human Diabetic Retina. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4928.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Hyperglycemia-induced up-regulation of the thioredoxin-inhibitory protein (TXNIP) has been shown to play a key role in the pro-oxidative and pro-inflammatory events leading to neurovascular injury and progression of diabetic retinopathy (DR). We have previously determined that TXNIP undergoes serine phosphorylation (TXNIP-SerP) in the diabetic milieu. Here, we have conducted studies to specifically identify and characterize TXNIP-SerP in the human diabetic retina.

Methods: Human post-mortem retinas were obtained from Georgia Eye Bank. Mass spectrometry analysis of phospho-enriched TXNIP immunoprecipitates was used to identify specific phosphoserine residues. Site-directed mutagenesis was used to generate TXNIP serine to alanine mutants (S-A) that were subsequently transfected in cultured retinal endothelial cells (REC) to assess their functional properties. Cell fractionation was used to determine the effects of TXNIP-S-A mutants and its intracellular redistribution in response to oxidative stimuli. Co-immunoprecipitation was used to assess TXNIP interaction with thioredoxin-1 (Trx-1) and the cryopyrin NALP3.

Results: Four most frequent sites of TXNIP SerP were identified in human diabetic retinas and these were Ser298, Ser300, Ser304 and Ser305. In in vitro assays using retinal endothelial cells (RECs) we have found that overexpression of all 4 TXNIP-S-A mutants significantly decreased TXNIP overexpression-induced production of free radicals, as demonstrated by loss of DCF-positive fluorescence. Overexpression of the inactive mutants S300A, S304A and S305A also blunted TXNIP-interaction with Trx-1, whereas S298A did not. However, overexpression of TXNIP S298A mutant demonstrated its selective ability to block TXNIP interaction with NALP3 in response to different stimuli including high glucose (25mM D-glucose).

Conclusions: The results of our studies provide new insights in the understanding of TXNIP pathological function in the diabetic human retina and its contribution to the pro-oxidative and pro-inflammatory mechanisms involved in DR pathogenesis.

Keywords: 634 oxidation/oxidative or free radical damage • 557 inflammation • 499 diabetic retinopathy  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.